After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
A novel Vertex Pharmaceuticals drug that takes a new ... come from their targeting of receptors in the central nervous system. But before pain signals reach the brain, they travel across pathways ...
17d
Zacks.com on MSNVertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You TradeIn the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $440.68, marking a -0.72% move from the previous day.
Time on MSN11d
FDA Approves the First Non-Opioid Pain Drug in 20 YearsThe prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Vertex Pharmaceuticals (VRTX ... a unique model that incorporates these estimate changes and offers a practical rating system. The Zacks Rank system, stretching from #1 (Strong Buy) to #5 ...
19d
Zacks.com on MSNVertex (VERX) Upgraded to Strong Buy: Here's WhyVertex (VERX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...
Its architect's daughter has cystic fibrosis—and benefits from a "miracle drug" backed by an agency he's attacking.
Keep your eye on the ball” is a motto for many athletes—and for astronomers trying to find Earth-threatening space rocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results